The mobile irradiation device INTRABEAM® was developed by Zeiss in order to irradiate tumors already during the surgery. In terms of communication, Zeiss faced the great challenge of convincing oncologists and radiation therapists of the new therapy option.
We took over the global communication for INTRABEAM®. We created press releases, articles for healthcare professionals and various print media.
With our great oncological expertise, we were able to convince oncologists and radiation therapists of INTRABEAM®. In the meantime, INTRABEAM® is perceived by the target group in selected indications as an equivalent alternative to conventional radiation therapy.